Study Name:
Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
Targeted Disease(s):
Other
Purpose of Study:
This clinical trial is designed to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Study Dates:
September 11, 2024 - December 1, 2028
Study Location:
Nationwide
Funding Source:
Mannkind Corporation
ClinicalTrails.gov Identifier:
NCT06418711
